🇺🇸 Oxaliplatin injection in United States

208 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 35 reports (16.83%)
  2. Dyspnoea — 31 reports (14.9%)
  3. Vomiting — 30 reports (14.42%)
  4. Diarrhoea — 21 reports (10.1%)
  5. Thrombocytopenia — 19 reports (9.13%)
  6. Neutropenia — 16 reports (7.69%)
  7. Paraesthesia — 15 reports (7.21%)
  8. Asthenia — 14 reports (6.73%)
  9. Hypersensitivity — 14 reports (6.73%)
  10. Chest Discomfort — 13 reports (6.25%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Oxaliplatin injection approved in United States?

Oxaliplatin injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Oxaliplatin injection in United States?

Akeso is the originator. The local marketing authorisation holder may differ — check the official source linked above.